Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.

• Risk models to predict prostate cancer on biopsy, whether they include only prostate-specific antigen (PSA) or other markers, are intended for use in all men of screening age. However, the association between PSA and cancer probably depends on a man's recent screening history.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Urology and Nephrology (hsv//eng)

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

Aged

Biopsy

Early Detection of Cancer

Forecasting

Humans

Kallikreins

analysis

Male

Middle Aged

Models

Statistical

Prostate-Specific Antigen

analysis

Prostatic Neoplasms

diagnosis

Randomized Controlled Trials as Topic

Tumor Markers

Biological

analysis

prostate specific antigen

prostate cancer

screening

kallikreins

molecular markers

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)